Literature DB >> 30582603

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy.

Eriko Katsuta1, Masanori Oshi2, Omar M Rashid3, Kazuaki Takabe4.   

Abstract

In vivo mouse models to assess breast cancer progression are essential for cancer research, including preclinical drug developments. However, the majority of the practical and technical details are commonly omitted in published manuscripts which, therefore, makes it challenging to reproduce the models, particularly when it involves surgical techniques. Bioluminescence technology allows for the evaluation of small amounts of cancer cells even when a tumor is not palpable. Utilizing luciferase-expressing cancer cells, we establish a breast cancer orthotopic inoculation technique with a high tumorigenesis rate. Lung metastasis is assessed utilizing an ex vivo technique. We, then, establish a mastectomy model with a low local recurrence rate to assess the metastatic tumor burden. Herein, we describe, in detail, the surgical techniques of orthotopic implantation and mastectomy for breast cancer with a high tumorigenesis rate and low local recurrence rates, respectively, to improve breast cancer model efficiency.

Entities:  

Mesh:

Year:  2018        PMID: 30582603     DOI: 10.3791/57849

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  6 in total

1.  Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.

Authors:  Maiko Okano; Masanori Oshi; Ali Butash; Ichiro Okano; Katsuharu Saito; Tsutomu Kawaguchi; Masayuki Nagahashi; Koji Kono; Toru Ohtake; Kazuaki Takabe
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-02-27       Impact factor: 2.673

2.  H2AX mRNA expression reflects DNA repair, cell proliferation, metastasis, and worse survival in breast cancer.

Authors:  Eriko Katsuta; Abhisha Sawant Dessai; John Ml Ebos; Li Yan; Toru Ouchi; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

3.  Conflicting roles of EGFR expression by subtypes in breast cancer.

Authors:  Masanori Oshi; Shipra Gandhi; Yoshihisa Tokumaru; Li Yan; Akimitsu Yamada; Ryusei Matsuyama; Takashi Ishikawa; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2021-10-15       Impact factor: 5.942

4.  Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors.

Authors:  Eriko Katsuta; Malgorzata Gil-Moore; Justine Moore; Mohamed Yousif; Alex A Adjei; Yi Ding; Justin Caserta; Carmen M Baldino; Kelvin P Lee; Irwin H Gelman; Kazuaki Takabe; Mateusz Opyrchal
Journal:  Int J Oncol       Date:  2022-08-03       Impact factor: 5.884

5.  High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer.

Authors:  Yoshihisa Tokumaru; Mariko Asaoka; Masanori Oshi; Eriko Katsuta; Li Yan; Sumana Narayanan; Nobuhiko Sugito; Nobuhisa Matsuhashi; Manabu Futamura; Yukihiro Akao; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Int J Mol Sci       Date:  2020-05-01       Impact factor: 5.923

6.  Conformational Modulation of Iduronic Acid-Containing Sulfated Glycosaminoglycans by a Polynuclear Platinum Compound and Implications for Development of Antimetastatic Platinum Drugs.

Authors:  Anil K Gorle; Thomas Haselhorst; Samantha J Katner; Arun V Everest-Dass; James D Hampton; Erica J Peterson; Jennifer E Koblinski; Eriko Katsuta; Kazuaki Takabe; Mark von Itzstein; Susan J Berners-Price; Nicholas P Farrell
Journal:  Angew Chem Int Ed Engl       Date:  2020-12-23       Impact factor: 15.336

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.